Pre-demographic dividend vs Saudi Arabia: Access to anti-retroviral drugs, male
Pre-demographic dividend
80.4%
in 2024
Saudi Arabia
93.0%
in 2024
Pre-demographic dividend rank
5th
Saudi Arabia rank
7th
Access to anti-retroviral drugs, male over time
- Pre-demographic dividend
- Saudi Arabia
How they compare
Saudi Arabia currently reports 93.0% against 80.4% in Pre-demographic dividend, a difference of 12.6%.
That makes Saudi Arabia's figure about 1.2 times Pre-demographic dividend's.
Across all 25 years both countries report, Saudi Arabia has been ahead every year.
Pre-demographic dividend ranks 5th and Saudi Arabia ranks 7th of 19 groups.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Pre-demographic dividend | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 27.0% | 21.3% | Saudi Arabia |
| 2010s | 37.6% | 56.4% | 18.8% | Saudi Arabia |
| 2020s | 71.5% | 91.2% | 19.7% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Pre-demographic dividend or Saudi Arabia?
- Saudi Arabia, at 93.0% against 80.4% in Pre-demographic dividend as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Pre-demographic dividend and Saudi Arabia?
- 12.6%, with Saudi Arabia ahead.
- How many years of comparable data are there for Pre-demographic dividend and Saudi Arabia?
- 25 years are reported by both, from 2000 to 2024.
- How do Pre-demographic dividend and Saudi Arabia rank globally for access to anti-retroviral drugs, male?
- Pre-demographic dividend ranks 5th and Saudi Arabia ranks 7th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.